受强制性开放获取政策约束的文章 - alina berriolo riedinger了解详情
无法在其他位置公开访问的文章：1 篇
MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PREDICTS OUTCOME IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMAS: A LYSA STUDY.
V Camus, P Viailly, P Sesques, F Drieux, E Veresezan, C Haioun, E Durot, ...
Hematological Oncology 41, 2023
强制性开放获取政策： Swiss Cancer League
可在其他位置公开访问的文章：8 篇
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
J Trotman, S Luminari, S Boussetta, A Versari, J Dupuis, C Tychyj, ...
The Lancet Haematology 1 (1), e17-e27, 2014
强制性开放获取政策： Government of Italy
Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant …
B Coudert, JY Pierga, MA Mouret-Reynier, K Kerrou, JM Ferrero, T Petit, ...
The Lancet Oncology 15 (13), 1493-1502, 2014
强制性开放获取政策： National Institute of Health and Medical Research, France
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project
C Bailly, T Carlier, A Berriolo-Riedinger, O Casasnovas, E Gyan, ...
Haematologica 105 (1), e33, 2020
强制性开放获取政策： Agence Nationale de la Recherche
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
V Camus, C Rossi, P Sesques, J Lequesne, D Tonnelet, C Haioun, ...
Blood advances 5 (19), 3862-3872, 2021
强制性开放获取政策： Swiss Cancer League
A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma
C Thieblemont, L Chartier, U Dührsen, U Vitolo, SF Barrington, ...
Blood advances 6 (23), 5995-6004, 2022
强制性开放获取政策： National Institute for Health Research, UK
High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma
V Camus, PJ Viailly, F Drieux, EL Veresezan, P Sesques, C Haioun, ...
Blood Advances 7 (23), 7331-7345, 2023
强制性开放获取政策： Swiss Cancer League
The Combination of High Total Metabolic Tumor Volume and Poor ECOG Performance Status Defines Ultra-High Risk Diffuse Large B-Cell Lymphoma. Validation across Multiple Cohorts …
C Thieblemont, L Chartier, U Dührsen, U Vitolo, SF Barrington, ...
Blood, The Journal of the American Society of Hematology 136 (Supplement 1 …, 2020
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA
Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
E Itti, P Blanc-Durand, A Berriolo-Riedinger, S Kanoun, F Kraeber-Bodéré, ...
Journal of Nuclear Medicine 64 (11), 1706-1711, 2023
强制性开放获取政策： Agence Nationale de la Recherche
出版信息和资助信息由计算机程序自动确定